An international research team, led by scientists from Tel Aviv University and Sheba Medical Center, has developed a groundbreaking method to activate adult stem cells from human bone marrow ...

A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose ...

My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

High Treatment Costs High treatment costs represent one of the most significant barriers in the GVHD treatment market, as patients face substantial financial challenges. The expenses associated with ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies ...

and stem cells. However, the efficacy of the bone marrow often declines as we grow older, leading to various health issues like anemia, fatigue, and a compromised immune system. Thus, the ...

This included using cells taken from human bone marrow, muscle-making cells harvested from donors, and embryonic stem cells extracted from fetuses. In the new procedure, scientists grab cells ...